SG11201408261UA - Syringe - Google Patents

Syringe

Info

Publication number
SG11201408261UA
SG11201408261UA SG11201408261UA SG11201408261UA SG11201408261UA SG 11201408261U A SG11201408261U A SG 11201408261UA SG 11201408261U A SG11201408261U A SG 11201408261UA SG 11201408261U A SG11201408261U A SG 11201408261UA SG 11201408261U A SG11201408261U A SG 11201408261UA
Authority
SG
Singapore
Prior art keywords
basel
international
postfach
november
january
Prior art date
Application number
SG11201408261UA
Other languages
English (en)
Inventor
Juergen Sigg
Christophe Royer
Andrew Mark Bryant
Heinrich Martin Buettgen
Marie Picci
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48051683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201408261U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2012101678A external-priority patent/AU2012101678B4/en
Priority claimed from AU2013100071A external-priority patent/AU2013100071C4/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SG11201408261UA publication Critical patent/SG11201408261UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A61M2005/3104—Caps for syringes without needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
    • A61M2005/3139—Finger grips not integrally formed with the syringe barrel, e.g. using adapter with finger grips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M2005/31508—Means for blocking or restricting the movement of the rod or piston provided on the piston-rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0612—Eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M5/31513—Piston constructions to improve sealing or sliding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201408261UA 2012-07-03 2013-01-25 Syringe SG11201408261UA (en)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
EP12174860 2012-07-03
EP12189649 2012-10-23
AU2012101678A AU2012101678B4 (en) 2012-07-03 2012-11-16 Use of device
DE202012011016U DE202012011016U1 (de) 2012-07-03 2012-11-16 Aflibercept-Spritze
AU2012101677A AU2012101677B4 (en) 2012-07-03 2012-11-16 Device
DE202012011260U DE202012011260U1 (de) 2012-07-03 2012-11-23 Ranibizumab-Spritze
DE202012011259U DE202012011259U1 (de) 2012-07-03 2012-11-23 Bevacizumab-Spritze
EP12195360 2012-12-03
AU2013100071A AU2013100071C4 (en) 2012-07-03 2013-01-23 Device
DE201320000688 DE202013000688U1 (de) 2012-07-03 2013-01-23 Glas-Spritze
AU2013100070A AU2013100070B4 (en) 2012-07-03 2013-01-23 Use of device
PCT/EP2013/051491 WO2014005728A1 (en) 2012-07-03 2013-01-25 Syringe

Publications (1)

Publication Number Publication Date
SG11201408261UA true SG11201408261UA (en) 2015-01-29

Family

ID=48051683

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201408261UA SG11201408261UA (en) 2012-07-03 2013-01-25 Syringe

Country Status (39)

Country Link
US (1) US9220631B2 (enExample)
EP (5) EP3470058A1 (enExample)
JP (2) JP5744927B2 (enExample)
KR (7) KR20230013282A (enExample)
CN (4) CN110115657A (enExample)
AR (1) AR090059A1 (enExample)
AU (1) AU2013201624A1 (enExample)
BR (2) BR122020020290B1 (enExample)
CA (1) CA2803566A1 (enExample)
CH (1) CH706741B1 (enExample)
CL (1) CL2014003619A1 (enExample)
CO (1) CO7151483A2 (enExample)
CY (2) CY1121497T1 (enExample)
DE (1) DE202013000688U1 (enExample)
DK (4) DK3656373T3 (enExample)
EA (1) EA031583B1 (enExample)
EC (1) ECSP15004005A (enExample)
ES (4) ES2912848T3 (enExample)
FR (1) FR2983077B1 (enExample)
GT (1) GT201400300A (enExample)
HR (4) HRP20220535T1 (enExample)
HU (3) HUE057746T2 (enExample)
IL (2) IL236296B (enExample)
JO (2) JOP20200175A1 (enExample)
LT (4) LT2869813T (enExample)
MA (1) MA37740B2 (enExample)
MX (1) MX358323B (enExample)
MY (1) MY164536A (enExample)
NZ (1) NZ702980A (enExample)
PE (1) PE20150196A1 (enExample)
PH (1) PH12014502785B1 (enExample)
PL (4) PL2869813T3 (enExample)
PT (1) PT2869813T (enExample)
SG (1) SG11201408261UA (enExample)
SI (4) SI3656373T1 (enExample)
TN (1) TN2014000517A1 (enExample)
TW (1) TWI632920B (enExample)
WO (1) WO2014005728A1 (enExample)
ZA (1) ZA201409411B (enExample)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614134B (zh) 2005-03-25 2016-09-07 瑞泽恩制药公司 Vegf拮抗剂制剂
RU2432155C3 (ru) 2006-06-16 2017-11-17 Ридженерон Фармасьютикалз, Инк. Составы антагониста vegf, подходящие для интравитреального введения
US11624115B2 (en) 2010-05-12 2023-04-11 Sio2 Medical Products, Inc. Syringe with PECVD lubrication
US9878101B2 (en) 2010-11-12 2018-01-30 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
EP2776603B1 (en) 2011-11-11 2019-03-06 SiO2 Medical Products, Inc. PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS
US11116695B2 (en) 2011-11-11 2021-09-14 Sio2 Medical Products, Inc. Blood sample collection tube
KR102232708B1 (ko) 2012-06-01 2021-03-30 노파르티스 아게 시린지
JOP20200175A1 (ar) 2012-07-03 2017-06-16 Novartis Ag حقنة
US20150297800A1 (en) 2012-07-03 2015-10-22 Sio2 Medical Products, Inc. SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS
US9764093B2 (en) 2012-11-30 2017-09-19 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
EP4234753A3 (en) 2013-03-11 2023-11-01 SiO2 Medical Products, Inc. Coated packaging
EP3254666B1 (en) * 2013-03-13 2019-10-16 Rush University Medical Center Delivery device and storage system for oropharyngeal administration of mother's colostrum and milk
US20140350518A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Syringe extrusion accessory
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
EP3122917B1 (en) 2014-03-28 2020-05-06 SiO2 Medical Products, Inc. Antistatic coatings for plastic vessels
WO2015173260A1 (en) * 2014-05-12 2015-11-19 Formycon Ag Pre-filled plastic syringe containing a vegf antagonist
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
TWI738632B (zh) 2014-11-07 2021-09-11 瑞士商諾華公司 穩定的含有高濃度抗vegf抗體之蛋白質溶液調配物
EP3058974A1 (en) 2015-02-19 2016-08-24 Sanofi-Aventis Deutschland GmbH Injection device with supplementary device
CN107743406B (zh) * 2015-03-23 2020-12-11 赛诺菲-安万特德国有限公司 注射装置
MA41906A (fr) 2015-04-10 2018-02-13 Dompe Farm Spa Dispositif de distribution de gouttes oculaires
CN108883057A (zh) * 2015-11-18 2018-11-23 Sio2医药产品公司 用于眼科配制品的药物包装
WO2018218013A2 (en) 2017-05-24 2018-11-29 Sio2 Medical Products, Inc. Sterilizable pharmaceutical package for ophthalmic formulations
EP3377151A1 (en) * 2015-11-18 2018-09-26 Formycon AG Pre-filled plastic syringe containing a vegf antagonist
WO2017087798A1 (en) * 2015-11-18 2017-05-26 Formycon Ag Pre-filled pharmaceutical package comprising a liquid formulation of a vegf-antagonist
PL3384049T3 (pl) 2015-12-03 2024-01-22 Regeneron Pharmaceuticals, Inc. Sposoby powiązania wariantów genetycznych z wynikiem klinicznym u pacjentów cierpiących na zwyrodnienie plamki związane z wiekiem, leczonych anty-vegf
KR20250057128A (ko) 2015-12-30 2025-04-28 코디악 사이언시스 인코포레이티드 항체 및 이의 접합체
RU2738018C2 (ru) * 2016-04-15 2020-12-07 Сантен Фармасьютикал Ко., Лтд. Точный, прецизионный микролитровый дозирующий шприц
US20170349313A1 (en) * 2016-06-01 2017-12-07 Centurion Medical Products Corporation Methods for manufacturing non-glass prefilled syringes
CN109312182B (zh) 2016-06-17 2021-12-24 花王株式会社 水性油墨
TWI737742B (zh) * 2016-06-22 2021-09-01 德商梅茲製藥有限兩合公司 肉毒桿菌毒素的預填充式注射器系統、具有其之套組以及其之使用
ITUA20162072A1 (it) * 2016-06-30 2017-12-30 Platinum Corp Srl Dropper a volume controllato
EP3502050B1 (en) 2016-08-22 2022-12-21 Fuji Corporation Method for producing aqueous hydrogen peroxide
US10537683B2 (en) 2016-11-03 2020-01-21 Johnson & Johnson Surgical Vision, Inc. Syringe finger grip
US10918754B2 (en) 2017-03-27 2021-02-16 Regeneron Pharmaceuticals, Inc. Sterilisation method
EP3609483A4 (en) 2017-04-12 2021-01-20 Urigen Pharmaceuticals, Inc. Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability
JP7165142B2 (ja) 2017-05-05 2022-11-02 アルコン インコーポレイティド 崩壊可能プランジャを含むシリンジ
EP3630043A1 (en) 2017-05-24 2020-04-08 Formycon AG Sterilizable pre-filled pharmaceutical packages comprising a liquid formulation of a vegf-antagonist
JP7098171B2 (ja) 2017-06-16 2022-07-11 クリーデンス メドシステムズ，インコーポレイテッド 安全シリンジのシステムおよび方法
US11590175B2 (en) 2017-08-23 2023-02-28 Merakris Therapeutics Llc Compositions containing amniotic components and methods for preparation and use thereof
FR3072297B1 (fr) * 2017-10-17 2023-05-12 Edix Sa Dispositif d'injection manuelle
WO2019118588A1 (en) 2017-12-13 2019-06-20 Regeneron Pharmaceuticals, Inc. Devices and methods for precision dose delivery
EP4309707A3 (en) 2018-02-02 2024-04-24 F. Hoffmann-La Roche AG Prefilled syringe and method of sterilizing a prefilled syringe
MX2020009152A (es) 2018-03-02 2020-11-09 Kodiak Sciences Inc Anticuerpos de il-6 y constructos de fusion y conjugados de los mismos.
WO2019199901A1 (en) * 2018-04-09 2019-10-17 Sio2 Medical Products, Inc. Stretchable plunger assemblies
US20210146054A1 (en) * 2018-04-24 2021-05-20 W. L. Gore & Associates, Inc. Medical Delivery Devices With Inhibited Oxygen Permeation
KR20210021299A (ko) 2018-05-10 2021-02-25 리제너론 파아마슈티컬스, 인크. 고농도 vegf 수용체 융합 단백질 함유 제제
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
US20210260300A1 (en) * 2018-06-01 2021-08-26 Sun Pharma Advanced Research Company Limited An injection device
WO2020086002A1 (en) * 2018-10-26 2020-04-30 Singapore Health Services Pte Ltd Device and method for ophthalmic extraction and injection
CA3119455C (en) 2018-11-13 2024-07-02 Credence Medsystems, Inc. MULTI-SITE INJECTION SYSTEM AND METHOD
WO2020109343A1 (en) 2018-11-29 2020-06-04 F. Hoffmann-La Roche Ag Combination therapy for treatment of macular degeneration
WO2020109344A1 (en) 2018-11-29 2020-06-04 F. Hoffmann-La Roche Ag Occular administration device for antisense oligonucleotides
JOP20210152A1 (ar) 2018-12-18 2023-01-30 Novartis Ag صياغة محلول بروتيني محتوية على تركيز عالٍ من جسم مضاد لـ vegf
CN110721026A (zh) * 2018-12-21 2020-01-24 南通市第一人民医院 一种眼科手术用取硅油装置防滑层的制备方法
EP3689397B1 (de) * 2019-01-31 2025-04-23 SCHOTT Pharma Schweiz AG Spritzenkörper, spritze und injektionsvorrichtung zum injizieren eines hochviskosen mediums
GB201902355D0 (en) * 2019-02-21 2019-04-10 New Injection Systems Ltd Modular auto injector
FR3093004B1 (fr) * 2019-02-21 2023-04-07 Dev Techniques Plastiques Procede de preparation d’une seringue
CA3131922A1 (en) 2019-02-28 2020-09-03 William Samuel Fagg, Iv Amniotic fluid-derived extracellular vesicles and uses thereof for wound healing
ES2902983T3 (es) * 2019-03-29 2022-03-30 Kortuc Inc Jeringa precargada con una solución de peróxido de hidrógeno que tiene una excelente capacidad de preservación del peróxido de hidrógeno debido al aceite de silicona (composición de aceite que contiene dicho aceite de silicona)
MX2021012683A (es) 2019-04-18 2021-11-12 Boehringer Ingelheim Int Dispositivo de administracion para la administracion de un fluido.
CN118718181A (zh) 2019-06-05 2024-10-01 里珍纳龙药品有限公司 用于精确剂量递送的装置及方法
WO2021019576A1 (en) * 2019-08-01 2021-02-04 Gennova Biopharmaceuticals Limited Opthalmic composition of bevacizumab
JP2022546082A (ja) 2019-09-03 2022-11-02 アムジエン・インコーポレーテツド 薬物送達のための注入デバイス及び注入デバイスのためのパッケージ
WO2021046245A1 (en) * 2019-09-04 2021-03-11 University Of Massachusetts Adeno-associated virus vector platform for delivery of kh902 (conbercept) and uses thereof
MX2022002980A (es) 2019-09-16 2022-04-06 Amgen Inc Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos.
CN114786731A (zh) 2019-10-10 2022-07-22 科达制药股份有限公司 治疗眼部病症的方法
EP4058108A2 (en) 2019-11-14 2022-09-21 Congruence Medical Solutions, LLC Variable dosing syringe
CN115335529A (zh) * 2019-11-26 2022-11-11 马萨诸塞大学 用于递送kh902(康柏西普)的重组腺相关病毒及其用途
EP4069164A2 (en) 2019-12-05 2022-10-12 F. Hoffmann-La Roche AG Syringe and tightness testing method
WO2021119544A1 (en) * 2019-12-12 2021-06-17 Novartis Ag Injection device and injection solution transferring system
JP7488331B2 (ja) * 2020-03-24 2024-05-21 テルモ株式会社 注射器バレル用グリップおよびバレル組立体ならびにシリンジ
WO2021257911A1 (en) 2020-06-17 2021-12-23 Credence Medsystems, Inc. System and method for microdose injection
JP2023550281A (ja) * 2020-10-30 2023-12-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 流体の特に硝子体内投与のための投与デバイス
KR20230117155A (ko) 2020-12-01 2023-08-07 베링거 인겔하임 인터내셔날 게엠베하 특히 유체의 유리체내 투여를 위한 투여 장치
KR102720956B1 (ko) 2020-12-15 2024-10-24 삼천당제약주식회사 안과용 제형을 포함하는 시린지
EP4271450A1 (en) * 2020-12-29 2023-11-08 W. L. Gore & Associates, Inc. Drug injection stopper with thin film lubricant
KR102419910B1 (ko) * 2021-04-15 2022-07-14 주식회사 알테오젠 저용량 약액 충전 사전 충전형 주사기 및 그 제조방법
US20250041523A1 (en) * 2021-12-01 2025-02-06 Sanofi Winthrop Industrie A Lubricating Shuttle
CN114146220B (zh) 2022-02-10 2022-04-29 中国远大集团有限责任公司 一种包含无菌pcl微球的美容产品
EP4389176A1 (en) 2022-12-20 2024-06-26 W. L. Gore & Associates, Inc. Low insertion force syringe stoppers, assemblies, and associated methods
EP4480517A1 (de) 2023-06-20 2024-12-25 Ypsomed AG Autoinjektor zur intravitrealen injektion
CA3237624A1 (en) * 2023-07-28 2025-04-24 Genentech, Inc. NEW USES FOR OMALIZUMAB
CN117942456B (zh) * 2024-03-27 2024-07-12 山东永聚医药科技股份有限公司 缓释型非牛顿流体制剂用预灌封注射器及其制备工艺
KR102828906B1 (ko) * 2024-11-18 2025-07-04 주식회사 비에스리서치 실리콘 오일이 미적용된 프리필드 시린지

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31789A (en) 1861-03-26 Bread-slicebi
DE2629557B2 (de) 1976-07-01 1980-05-14 Paul E. Dr.Med. 8000 Muenchen Doerr Einmai-Injektionsspritze
JPH0747045B2 (ja) 1986-10-15 1995-05-24 株式会社大協精工 積層した注射器用滑栓
US4946441A (en) 1988-07-21 1990-08-07 Maurice Laderoute Limited use hypodermic syringe
JPH0725963Y2 (ja) 1989-11-06 1995-06-14 清坤 曽 緊急避難装置
US5290228A (en) * 1990-11-17 1994-03-01 Santen Seiyaku Kabushiki Kaisha Two-compartment syringe
US5236604A (en) * 1991-05-29 1993-08-17 Sherwood Medical Company Serum separation blood collection tube and the method of using thereof
JP3186422B2 (ja) 1993-05-14 2001-07-11 武田薬品工業株式会社 プラスチゾル
US5405326A (en) 1993-08-26 1995-04-11 Habley Medical Technology Corporation Disposable safety syringe with retractable shuttle for luer lock needle
US5795337A (en) 1994-02-14 1998-08-18 Becton Dickinson And Company Syringe assembly and syringe stopper
US5688252A (en) 1994-09-30 1997-11-18 Takeda Chemical Industries, Ltd. Syringe
US5667495A (en) 1995-04-21 1997-09-16 Becton Dickinson France S.A. Backstop device for a syringe
US5607400A (en) * 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
DE19622283A1 (de) 1996-05-23 1997-11-27 Schering Ag Verfahren zur terminalen Sterilisierung von befüllten Spritzen
JP4078406B2 (ja) * 1997-01-22 2008-04-23 有限会社コーキ・エンジニアリング 注射器のシリンダの製造方法
WO1998045331A2 (en) 1997-04-07 1998-10-15 Genentech, Inc. Anti-vegf antibodies
JP3387775B2 (ja) * 1997-05-22 2003-03-17 株式会社大協精工 注射器用密封栓及びプレフィルド注射器
US6200627B1 (en) * 1998-03-17 2001-03-13 Becton, Dickinson And Company Low silicone glass prefillable syringe
JP2002515268A (ja) * 1998-04-30 2002-05-28 アボット・ラボラトリーズ 注射器アセンブリ
USD430015S (en) 1998-06-11 2000-08-29 Pharmacia & Upjohn Ab Blister pack for a syringe
JP2001104480A (ja) 1999-10-05 2001-04-17 Daikyo Seiko Ltd プラスチック製プレフィルド注射器の密封に使用するゴム製ピストン
JP2001340455A (ja) 2000-05-31 2001-12-11 Yoshino Kogyosho Co Ltd シリンジ容器
JP2002177388A (ja) 2000-12-15 2002-06-25 Daikyo Seiko Ltd 医薬・医療用既充填注射器
JP2002241264A (ja) 2001-02-19 2002-08-28 Asahi Kasei Corp エルカトニンのプレフィルドシリンジ製剤
WO2003055546A1 (en) * 2001-12-27 2003-07-10 Showa Yakuhin Kako Co., Ltd. Cartridge syringe, cartridge and ophthalmologic syringe set having such syringe
JP4141156B2 (ja) 2002-03-15 2008-08-27 日本ベクトン・ディッキンソン株式会社 プランジャ後退制限機構付きプレフィルドシリンジ
US6688252B1 (en) 2002-12-11 2004-02-10 Gary Caravella Boat cover
US20050010175A1 (en) 2003-02-27 2005-01-13 Beedon Daniel E. Piston assembly for syringe
JP2004313369A (ja) 2003-04-15 2004-11-11 Menicon Co Ltd カートリッジ注入器、カートリッジ及び該注入器を備えた眼科用注入器セット
FR2855413B1 (fr) 2003-05-26 2005-12-30 Becton Dickinson France Seringue pre-remplie avec coiffe anti effraction
KR20060130648A (ko) * 2004-01-12 2006-12-19 아이싸이언스 인터벤셔날 코포레이션 점성 물질용 인젝터
US8124207B2 (en) 2004-03-02 2012-02-28 Sakhrani Vinay G Article with lubricated surface and method
KR100897379B1 (ko) 2004-06-08 2009-05-14 쳉두 캉홍 바이오테크놀로지스 코. 리미티드 혈관신생-저해 키메릭 단백질 및 그 사용
EP2324848A3 (en) 2004-10-21 2011-09-14 Genentech, Inc. Method for treating intraocular neovascular diseases
AU2006214658A1 (en) * 2005-02-02 2006-08-24 Regeneron Pharmaceuticals, Inc. Method of treating eye injury with local administration of a VEGF inhibitor
US20080312607A1 (en) * 2005-05-31 2008-12-18 Baxter International Inc. Polypropylene Hollow Barrel with Sliding Coated Rubber Piston
US20060293270A1 (en) * 2005-06-22 2006-12-28 Adamis Anthony P Methods and compositions for treating ocular disorders
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
FR2890316B1 (fr) * 2005-09-02 2007-10-05 Aguettant Soc Par Actions Simp Seringue destinee a etre remplie puis sterilisee par autoclavage a la vapeur.
CA2622573A1 (en) * 2005-09-16 2007-03-29 (Osi) Eyetech, Inc. Ophthalmic syringe
WO2007035623A1 (en) 2005-09-17 2007-03-29 Technology Group Northwest Inc. System and method for foiling code-injection attacks in a computing device
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
ZA200803814B (en) * 2005-10-14 2010-02-24 Alcon Inc Method for treating primary and secondary forms of glaucoma
AT502791B1 (de) * 2006-04-06 2007-05-15 Pharma Consult Ges M B H & Co Injektionsspritze
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
CA2651194A1 (en) * 2006-05-04 2007-11-15 Fondation Ophthalmologique Aldolphe De Rothschild Methods for treating neovascular diseases
RU2432155C3 (ru) 2006-06-16 2017-11-17 Ридженерон Фармасьютикалз, Инк. Составы антагониста vegf, подходящие для интравитреального введения
JP4131001B2 (ja) 2006-07-28 2008-08-13 大成化工株式会社 定量吐出装置
CN200973886Y (zh) * 2006-11-20 2007-11-14 骆忠林 一种注射器
WO2008077155A1 (en) 2006-12-21 2008-06-26 Genentech, Inc. Sterilization of objects containing biological molecules
US8529521B2 (en) 2007-04-23 2013-09-10 Ultimed Inc. Low-dosage syringe
CN100563736C (zh) * 2007-06-02 2009-12-02 丁锐 一次性防刺伤注射器
JP5393660B2 (ja) 2007-06-12 2014-01-22 ベクトン・ディキンソン・アンド・カンパニー 不能化機構付き注射器
EP2020245B1 (en) * 2007-07-31 2011-11-30 AL.CHI.MI.A. S.r.l. Method for making a device for ophthalmic treatments
WO2009030975A1 (en) 2007-09-03 2009-03-12 Becton Dickinson France Medical device comprising a siliconized chamber and a coated closure means
WO2009030976A1 (en) 2007-09-03 2009-03-12 Becton Dickinson France Medical device and smooth coating therefor
DE102008005938A1 (de) * 2008-01-24 2009-07-30 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Vorgefüllte Spritze und Verfahren zum Verpacken einer Spritze
ATE533963T1 (de) 2008-01-24 2011-12-15 Meflex Telecontrol Gmbh & Co Kg Abschlusskappe für ein antriebskabel, antriebskabel, verfahren zur herstellung einer abschlusskappe sowie verfahren zur herstellung eines antriebskabels
CN102202643A (zh) 2008-02-07 2011-09-28 安姆根有限公司 稳定化的蛋白组合物
CA2728145A1 (en) 2008-06-17 2009-12-23 Denki Kagaku Kogyo Kabushiki Kaisha Injector
WO2009158613A1 (en) 2008-06-26 2009-12-30 West Pharmaceutical Services, Inc. Method of coating polyxylylene onto flouropolymer surfaces and devices coated thereby
US8221353B2 (en) 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
WO2010060748A1 (en) 2008-11-03 2010-06-03 Molecular Partners Ag Binding proteins inhibiting the vegf-a receptor interaction
AU2009323307B2 (en) 2008-12-03 2015-02-19 Denki Kagaku Kogyo Kabushiki Kaisha Syringe
JP2012525415A (ja) * 2009-05-01 2012-10-22 オプソテツク・コーポレイシヨン 眼科疾患を処置または予防するための方法
WO2010136492A2 (en) 2009-05-28 2010-12-02 Glaxo Group Limited Antigen-binding proteins
EP2266647A1 (en) * 2009-06-25 2010-12-29 Sanofi-Aventis Deutschland GmbH Drive mechanism for drug delivery device
AR078060A1 (es) 2009-07-14 2011-10-12 Novartis Ag Descontaminacion de superficie de contenedores previamente llenados en empaque secundario
CN102725012B (zh) 2009-10-29 2016-01-06 W.L.戈尔及同仁股份有限公司 涂覆膨胀型ptfe的注射器塞
CN201578690U (zh) 2010-01-21 2010-09-15 王建友 一种注射器
CA2795096C (en) 2010-03-31 2021-10-26 Ocuject, Llc Device and method for intraocular drug delivery
US9408746B2 (en) 2010-03-31 2016-08-09 Ocuject, Llc Device and method for intraocular drug delivery
AR081361A1 (es) 2010-04-30 2012-08-29 Molecular Partners Ag Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a
JP2012045046A (ja) 2010-08-24 2012-03-08 Gc Corp 歯科用シリンジ
FR2966044B1 (fr) 2010-10-18 2012-11-02 Sanofi Pasteur Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium
US10034981B2 (en) 2011-03-01 2018-07-31 Terumo Kabushiki Kaisha Syringe and syringe assembly
LT2701773T (lt) 2011-04-25 2019-07-10 Icon Bioscience, Inc. Injekcinio švirkšto dozės kreiptuvai
US20130012918A1 (en) 2011-07-07 2013-01-10 Gary Foster Steady grip ophthalmic surgical syringe and method
ES2944088T3 (es) 2011-09-27 2023-06-19 Becton Dickinson France Uso de aceite de silicona tratado con plasma como recubrimiento en un dispositivo médico de inyección
US9421129B2 (en) 2012-04-02 2016-08-23 Ocuject, Llc Intraocular delivery devices and methods therefor
US10780228B2 (en) 2012-05-07 2020-09-22 Medline Industries, Inc. Prefilled container systems
KR102232708B1 (ko) 2012-06-01 2021-03-30 노파르티스 아게 시린지
JOP20200175A1 (ar) 2012-07-03 2017-06-16 Novartis Ag حقنة
DE202012011016U1 (de) 2012-07-03 2012-11-28 Novartis Ag Aflibercept-Spritze
AU2013100070B4 (en) 2012-07-03 2013-04-04 Novartis Ag Use of device
US9662450B2 (en) * 2013-03-01 2017-05-30 Sio2 Medical Products, Inc. Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus

Also Published As

Publication number Publication date
ES2912848T3 (es) 2022-05-30
HRP20220535T1 (hr) 2022-07-08
PL3381444T3 (pl) 2021-11-22
CN110115657A (zh) 2019-08-13
JOP20200175A1 (ar) 2017-06-16
EP3381444A1 (en) 2018-10-03
KR102092427B1 (ko) 2020-04-17
LT3685826T (lt) 2022-02-10
PH12014502785A1 (en) 2015-02-02
KR102487296B9 (ko) 2024-12-30
EP2869813A1 (en) 2015-05-13
EP3470058A1 (en) 2019-04-17
BR112014032990A2 (pt) 2018-03-06
TN2014000517A1 (en) 2016-03-30
KR102341670B9 (ko) 2024-12-18
LT2869813T (lt) 2019-03-12
KR20230013282A (ko) 2023-01-26
ES2712152T3 (es) 2019-05-09
ECSP15004005A (es) 2018-10-31
EP3656373B1 (en) 2022-02-16
DK3656373T3 (da) 2022-05-16
BR112014032990B1 (pt) 2022-01-04
CA2803566A1 (en) 2014-01-03
LT3381444T (lt) 2021-08-25
ES2882254T3 (es) 2021-12-01
JP2014028114A (ja) 2014-02-13
DE202013000688U1 (de) 2013-03-05
KR102487296B1 (ko) 2023-01-13
KR102395557B9 (ko) 2024-12-18
US20140012227A1 (en) 2014-01-09
EP3685826B1 (en) 2021-11-03
EP3656373A1 (en) 2020-05-27
HRP20211216T1 (hr) 2021-10-29
FR2983077A1 (fr) 2013-05-31
SI3656373T1 (sl) 2022-06-30
EP3685826A1 (en) 2020-07-29
KR20150030216A (ko) 2015-03-19
KR102395557B1 (ko) 2022-05-09
PE20150196A1 (es) 2015-03-02
US9220631B2 (en) 2015-12-29
GT201400300A (es) 2015-10-15
IL272915B (en) 2021-02-28
JO3655B1 (ar) 2020-08-27
KR20220062681A (ko) 2022-05-17
AR090059A1 (es) 2014-10-15
AU2013201624A1 (en) 2014-01-23
HK1188404A1 (en) 2014-05-02
PL3685826T3 (pl) 2022-03-21
KR20220130821A (ko) 2022-09-27
IL272915A (en) 2020-04-30
PL2869813T3 (pl) 2019-05-31
DK3381444T3 (da) 2021-08-09
PL3656373T3 (pl) 2022-06-20
MX2014015743A (es) 2015-07-23
KR102299177B1 (ko) 2021-09-08
SI2869813T1 (sl) 2019-04-30
CN111249062A (zh) 2020-06-09
PT2869813T (pt) 2019-02-27
DK2869813T3 (en) 2019-03-18
CL2014003619A1 (es) 2015-10-02
HRP20220083T1 (hr) 2022-04-15
FR2983077B1 (fr) 2018-09-14
CH706741B1 (de) 2014-02-14
SI3685826T1 (sl) 2022-02-28
IL236296B (en) 2020-04-30
TWI632920B (zh) 2018-08-21
EA201590139A1 (ru) 2015-07-30
SI3381444T1 (sl) 2021-09-30
KR102299177B9 (ko) 2024-12-18
MA37740B2 (fr) 2020-10-28
TW201402152A (zh) 2014-01-16
CY1121497T1 (el) 2020-05-29
HUE055227T2 (hu) 2021-11-29
CN112972828A (zh) 2021-06-18
ZA201409411B (en) 2015-11-25
ES2906812T3 (es) 2022-04-20
HRP20190300T1 (hr) 2019-04-05
KR20210113413A (ko) 2021-09-15
CH706741A2 (de) 2014-01-15
MA37740A1 (fr) 2016-11-30
KR20200029611A (ko) 2020-03-18
IL236296A0 (en) 2015-02-26
KR102443606B9 (ko) 2024-12-18
KR20210156865A (ko) 2021-12-27
HUE042652T2 (hu) 2019-07-29
NZ702980A (en) 2017-06-30
JP6313038B2 (ja) 2018-04-18
PH12014502785B1 (en) 2015-02-02
CN104427972A (zh) 2015-03-18
KR102341670B1 (ko) 2021-12-22
JP5744927B2 (ja) 2015-07-08
DK3685826T3 (da) 2022-02-14
LT3656373T (lt) 2022-05-10
JP2014087678A (ja) 2014-05-15
CO7151483A2 (es) 2014-12-29
MX358323B (es) 2018-08-14
BR122020020290B1 (pt) 2022-04-05
EP3381444B1 (en) 2021-05-19
KR102443606B1 (ko) 2022-09-14
EA031583B1 (ru) 2019-01-31
EP2869813B1 (en) 2018-11-21
CY1124431T1 (el) 2022-07-22
HUE057746T2 (hu) 2022-06-28
WO2014005728A1 (en) 2014-01-09
MY164536A (en) 2017-12-29

Similar Documents

Publication Publication Date Title
SG11201408261UA (en) Syringe
SG11201408174UA (en) Antibody formulation
SG11201407580YA (en) Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201809912UA (en) Hybrid carriers for nucleic acid cargo
SG11201408646VA (en) Dimeric protein with triple mutations
SG11201407534PA (en) New diazaspirocycloalkane and azaspirocycloalkane
SG11201407241QA (en) Syringe
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201804729RA (en) Methods and compositions for treating a serpinc1-associated disorder
SG11201408095XA (en) Fibroblast growth factor 21 proteins
SG11201408769QA (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
SG11201408318RA (en) Compositions and methods for transmucosal absorption
SG11201804170RA (en) Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
SG11201805570WA (en) Systems and methods for long term transdermal administration
SG11201803920TA (en) Compounds and compositions useful for treating disorders related to ntrk
SG11201407417VA (en) Encoding and reconstruction of residual data based on support information
SG11201407851RA (en) Synthesis of pyrrolo [2, 3 - b] pyridines
SG11201407200TA (en) Liquid formulation
SG11201408054RA (en) Pegylated oxm variants
SG11201810628XA (en) Nasal pharmaceutical compositions with a porous excipient
SG11201406973PA (en) Complement pathway modulators and uses thereof
SG11201407860PA (en) Exendin-4 peptide analogues
SG11201407655TA (en) Therapeutic uses of fibroblast growth factor 21 proteins
SG11201406787TA (en) Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same